Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis
- 30 June 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 101 (6), 555-563
- https://doi.org/10.1016/j.trstmh.2006.12.004
Abstract
The potential of repeated mass administration of diethylcarbamazine (DEC) and ivermectin to eliminate lymphatic filariasis has been examined in a study implemented in 10 villages with a population of 18415 in south India. During ten rounds of mass drug administration, 49-84% of the eligible population received treatment in different villages. Ten rounds of mass administration of DEC alone reduced the microfilaria (mf) prevalence and intensity by 93% and 97%, respectively, and the vector infection and infectivity rates by 91% and 89%, respectively. The corresponding figures with nine rounds of administration of ivermectin alone were 83%, 90%, 89% and 79%. Out of five villages in each treatment arm, the mf rate declined to <or=1% in four villages in the DEC arm and two villages in the ivermectin arm. No mosquitoes with infective-stage larvae were found in three of five villages in the DEC arm and two of five villages in the ivermectin arm. None of the children (n=130) were found to be positive for mf in either treatment arm. None of the 40 sampled children were found to be positive for circulating filarial antigenaemia in villages with lower endemicity in the DEC arm. The results suggest that ten rounds of DEC mass administration have the potential to interrupt transmission of infection in the majority of communities. The outcome was relatively less remarkable with ivermectin.Keywords
This publication has 17 references indexed in Scilit:
- Community‐based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south IndiaTropical Medicine & International Health, 2006
- EVALUATION OF THE PROGRAM TO ELIMINATE LYMPHATIC FILARIASIS IN VANUATU FOLLOWING TWO YEARS OF MASS DRUG ADMINISTRATION IMPLEMENTATION: RESULTS AND METHODOLOGIC APPROACHThe American Journal of Tropical Medicine and Hygiene, 2005
- Mass drug administration to eliminate lymphatic filariasis in IndiaTrends in Parasitology, 2004
- Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, IndiaTropical Medicine & International Health, 2004
- RELATIONSHIPS BETWEEN WUCHERERIA BANCROFTI MICROFILARIA COUNTS IN HUMAN BLOOD AND PARASITE UPTAKE AND MATURATION IN CULEX PIPIENS, WITH OBSERVATIONS ON THE EFFECTS OF DIETHYLCARBAMAZINE TREATMENT ON THESE PARAMETERSThe American Journal of Tropical Medicine and Hygiene, 2003
- Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in GhanaPathogens and Global Health, 2001
- The Economic Burden of Lymphatic Filariasis in IndiaParasitology Today, 2000
- Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Seasonality of adult Culex quinquefasciatus and transmission of bancroftian filariasis in Pondicherry, South IndiaActa Tropica, 1992
- Filariasis eradication on Kinmen Proper, Kinmen (Quemoy) Islands, Republic of ChinaActa Tropica, 1990